Our mission

We are a team of doctors, lawyers, designers, and biopharma industry professionals dedicated to solving the fundamental matchmaking problem in the industry.

We created BIOCAPX™, an investment platform that facilitates the global funding and trading of biopharmaceutical IP rights. We help biotechs secure funds, save transaction time, and save execution costs. Our platform automates end-to-end processes for phase I & II clinical trial programs.

We created BIOCAPX™, an investment platform that facilitates the global funding and trading of biopharmaceutical IP rights. We help biotechs secure funds, save transaction time, and save execution costs. Our platform automates end-to-end processes for phase I & II clinical trial programs.

Value Proposition for the Ecosystem

BIOCAPX brings together the key stakeholders in pharma R&D. We digitize the drug development ecosystem, securitize the pharma clinical trial process, and allow investors to enter and exit portfolios seamlessly.

Biotechs

Comission projects for global network of BIOTECHS to close a wide market gap

Pharmacos

Offer PHAMARCOS risk-sharing, licencing & novel partnering with R&D teams and Investors

CROs

Match Contract Research Organizations (CROs) with the best projects and relationships

Investors

Expose INVESTORS to oppurtinities for assymetric returns on a unique asset class

Traders

Securitize Pharma R&D process for TRADERS to participate in a secondary market

Foundations and Endowments

Help FOUNDATIONS and ENDOWMENTS remedy neglected diseases

BIOCAPX for Biotechs

We help biotechs address pain points critical to the success of R&D efforts:

  • We secure investors for clinical trials – saving significant time and expense

  • We offer the opportunity to open new indications and clinical trials for the same compound, rights are separated from other indications and the company’s other assets

  • We offer legal and financial safe haven with Swiss banking and legal background – to safeguard both biotech companies’ and investors’ interests

  • Our standardized contracts streamline transactions and facilitate efficient licensing

  • Our unique fund structure automates CRO contracting and reserves decision-making and IP rights to biotechs

  • We help biotechs build novelty partnerships with other stakeholders

  • Our broad investor base helps biotechs keep self-governance and reduce corporate vulnerability

How it Works

BIOCAPX automates the end-to-end process of clinical trials, saving funding time and reducing project costs. This process lasts from when a program is onboarded, until the asset is auctioned. Our platform introduces efficiency, transparency and liquidity to the drug development industry, which fosters R&D.

Our coverage

Our current focus is phase I & II clinical trial programs globally, with over 18,000 trials seeking funding today.

Oncology – 4,176 – 23%
Neurology – 2,513 – 14%
Anti-Infective – 2,221 – 12%
Metabolic – 1,999 – 11%
Musculoskeletal – 1,499 – 8%
Cardiovascular – 950 – 5%
Immunological – 869 – 5%
Others – 3,991 – 22%

Onboarding

We welcome biotech companies, investors and CROs to register to the scheme. Please visit the platform to sign up or contact us for more information.

We advise to provide the following information to list a trial program:

  • Disease and burden of disease, epidemiology, narrower indication, patient subgroup by genetic background or biomarkers (if available)

  • Current treatment options, unmet need, compound profile and value story

  • Patent status

  • Preclinical results, clinical trial design plans, required budget

Contact

US +1 518 598 95 76 – New York, United States

CH +41 58 658 29 15 – Zurich, Switzerland

info@biocapx.com